Tscan Therapeutics, Inc. · NASDAQ:TCRX

Lynx1 Capital Management LP reported a 15.00% stake in Tscan Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Lynx1 Capital Management LP reported a 15.00% stake in Tscan Therapeutics, Inc., 7,857,347 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
15.00%
Shares
7,857,347
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Lynx1 Capital Management LP15.00%7,857,347
Weston Nichols15.00%7,857,347

Source

View original at SEC

Related